The pharmacotherapy for tobacco cessation continues to evolve with new treatment options. Join host, Geoff Wall, with guest, Jake Galdo, as they discuss the role of the pharmacy team in tobacco cessation.
 
The GameChanger
Pharmacotherapy alone may not be sufficient for tobacco cessation - counseling and support are often required. A new medication, cytisinicline, may provide additional options for treatment.
 
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
Jake Galdo, PharmD, MBA, BCPS, BCGP
Course Content and Developer, CEimpact
Managing Network Facilitator, CPESN Health Equity
CEO, Seguridad
 
Reference
Rigotti NA, Benowitz NL, Prochaska J, et al. Cytisinicline for Smoking Cessation: A Randomized Clinical Trial. JAMA. 2023 Jul 11;330(2):152-160. doi: 10.1001/jama.2023.10042. PMID: 37432430; PMCID: PMC10336611.

https://jamanetwork.com/journals/jama/article-abstract/2807079
 
Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss obstacles to effective tobacco cessation therapy
2. Compare and contrast cytisinicline with other pharmacotherapy agents for tobacco cessation

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-287-H01-P
Initial release date: 8/14/2023
Expiration date: 8/14/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram